FDA warns Hospira over Costa Rica infusion device plant
Aug 28 (Reuters) - Hospira Inc said it has received a warning letter from the U.S. Food and Drug Administration stemming from an April inspection of the medical device maker's manufacturing plant in La Aurora de Heredia, Costa Rica.
The Aug. 23 letter does not restrict production or shipment of products from the plant, where the company makes most of its infusion devices and sets, Hospira said.
- Tweet this
- Share this
- Digg this
DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.